Table 4.
Medications used in hospital and after discharge.
| Variables | 1st group (n = 401) | 2nd group (n = 400) | 3rd group (n = 402) | p value |
|---|---|---|---|---|
| Asprins | 394 (98.3%) | 395 (98.8%) | 395 (98.3%) | 0.811 |
| Clopidogrel | 379 (94.5%) | 386 (96.5%) | 380 (94.5%) | 0.320 |
| Ticagrelor | 14 (3.5%) | 12 (3.0%) | 15 (3.7%) | 0.844 |
| Tirofiban | 90 (22.4%) | 89 (22.3%) | 84 (20.9%) | 0.846 |
| Bivalirudin | 21 (5.2%) | 17 (4.3%) | 17 (4.3%) | 0.737 |
| β-Blockers | 336 (83.8%) | 336 (84.0%) | 329 (81.8%) | 0.665 |
| ACEI | 351 (87.5%) | 356 (89.0%) | 351 (87.3) | 0.728 |
| ARB | 23 (5.7%) | 33 (8.3%) | 30 (7.5%) | 0.368 |
| CCB | 34 (8.5%) | 52 (13.0%) | 54 (13.4%) | 0.053 |
| Statins | 393 (98.0%) | 394 (98.5%) | 395 (98.3%) | 0.867 |
| LMWH | 394 (98.3%) | 391 (97.8%) | 390 (97.0%) | 0.503 |
| PPI | 223 (55.6%) | 209 (52.3%) | 243 (60.4%) | 0.063 |
| Diuretics | 185 (46.1%) | 182 (45.5%) | 184 (45.8%) | 0.984 |
| Antibiotic | 79 (19.7%) | 80 (20.0%) | 92 (22.9%) | 0.471 |
| OAD | 83 (20.7%) | 106 (26.5%) | 90 (22.4%) | 0.135 |
| Insulin | 99 (24.7%) | 105 (26.3%) | 95 (23.6%) | 0.689 |
Data are shown as n (%).
ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; CCB, calcium channel blockers; LMWH, low molecular weight heparins; PPI, proton pump inhibitors; OAD, oral antidiabetic drug.